Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction
The Journal of Clinical Endocrinology & Metabolism · 18.11.2026 · 111 (12) · 3475-3493
DOI: 10.1210/clinem/dgag246 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 24.06.2026. Verfasst von Shámila Ismael und 18 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition & Metabolism, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa 1169-056, Portugal. Hauptthemen laut MEDLINE: Adipose Tissue, Gastrointestinal Microbiome, DNA, Bacterial, Obesity. Die Arbeit nennt 59 Literaturangaben. Gefördert von: ERDF, Programa Operacional Competitividade e Internacionalização, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Context
Obesity-related metabolic complications are especially driven by adipose tissue dysfunction. Gut dysbiosis and impaired intestinal barrier function facilitate microbial fragment translocation, potentially promoting metabolic impairment. However, the presence and functional impact of microbial DNA in adipose tissue and its contribution to metabolic dysfunction remain unclear.
Objective
To investigate the role of gut microbiota, intestinal barrier function, and adipose tissue-associated microbial DNA in obesity-related metabolic dysfunction.
Design
Exploratory cross-sectional study with complementary mechanistic in vitro experiments.
Setting
Academic tertiary referral center in Lisbon, Portugal.
Participants
Fifty adults with severe obesity undergoing laparoscopic Roux-en-Y gastric bypass surgery were recruited and stratified according to metabolic phenotype into preclinical obesity and clinical obesity. Main Outcome Measures Gut microbiota composition, intestinal barrier markers, adipose tissue-associated microbial DNA profiles, and adipocyte functional responses to adipose tissue-derived microbial DNA.
Results
Clinical obesity was associated with higher protein intake, impaired gut barrier function, and enrichment of hydrogen sulfide–producing genera (Bilophila, Desulfovibrio), whereas preclinical obesity showed higher Akkermansia and Bifidobacterium. Adipose tissue from clinical obesity contained more microbial DNA, with reduced diversity and partial overlap with gut profiles. Functionally, adipose-derived microbial DNA from clinical obesity induced increased oxidative stress, IL-1β, and NFκB expression, and a lower adiponectin/leptin gene expression ratio in adipocytes compared with preclinical obesity DNA.
Conclusion
Clinical obesity is characterized by distinct gut microbiota signatures, impaired intestinal barrier function, and increased adipose-associated microbial DNA. Adipose tissue-derived DNA promoted adipocyte dysfunction in vitro, supporting a potential role for the gut–adipose tissue microbial axis in obesity-related metabolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition & Metabolism, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa 1169-056, Portugal.
- CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa 1169-056, Portugal.
- RISE-Health, Faculdade de Medicina, Universidade do Porto, Porto 4200-319, Portugal.
- Obesity and Metabolic Surgery Unit, Hospital CUF Tejo, Lisboa 1350-352, Portugal.
- Unidade Universitária Lifestyle Medicine José de Mello Saúde by NOVA Medical School, Lisboa 1350-352, Portugal.
- EPIUnit-Institute of Public Health, Universidade do Porto, Porto 4050-600, Portugal.
ORCID-Profile: Shámila Ismael, Martin Wabitsch, Cláudia Marques
Förderung
- ERDF
- Programa Operacional Competitividade e Internacionalização
- Fundação para a Ciência e a Tecnologia
- CINTESIS
- R&D Unit
- CHRC
- Projetos de investigação clínica
- European Society for Clinical Investigation
Zitieren
APA
Ismael, S., Vaz, C., Durão, C., Tavares, A., Rodrigues, C., Almeida, M. J., Santos, G. M., Castela, I., Cabral, F., Toscano, F., Galindo, L., Wabitsch, M., Pestana, D., Araújo, J. R., Silvestre, M. P., Calhau, C., Faria, A., Teixeira, D., & Marques, C. (2026). Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction. The Journal of Clinical Endocrinology & Metabolism, 111(12), 3475-3493. https://doi.org/10.1210/clinem/dgag246
Vancouver
Ismael S, Vaz C, Durão C, Tavares A, Rodrigues C, Almeida MJ, et al. Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction. The Journal of Clinical Endocrinology & Metabolism. 2026;111(12):3475-3493. doi:10.1210/clinem/dgag246
BibTeX
@article{Ismael2026,
author = {Ismael, Shámila and Vaz, Carlos and Durão, Catarina and Tavares, Ana and Rodrigues, Catarina and Almeida, Maria João and Santos, Gilberto Maia and Castela, Inês and Cabral, Francisco and Toscano, Francisco and Galindo, Luís and Wabitsch, Martin and Pestana, Diogo and Araújo, João Ricardo and Silvestre, Marta P and Calhau, Conceição and Faria, Ana and Teixeira, Diana and Marques, Cláudia},
title = {Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {12},
pages = {3475--3493},
doi = {10.1210/clinem/dgag246}
}
EUVIMED